Rankings / Hormones & Endocrine

Elinzanetant (Lynkuet)

Hormones & Endocrine · NK1/NK3 dual receptor antagonist (non-hormonal)

Tier A-

methylationprescription
7.6 / 10
Tier A-
Ev 8 Bn 8 Sf 7

Bottom line

Read Off Label grades Elinzanetant (Lynkuet) as A- (7.6/10) based on strong evidence, high benefit magnitude, and a low-med-risk safety profile.

Bayer; brand Lynkuet.

Typical use: 120 mg PO once daily — Rx.

What this is

Bayer; brand Lynkuet. The NK1 addition provides a sleep/mood advantage that may make elinzanetant the preferred non-hormonal VMS therapy where available — especially since liver monitoring isn't required (vs fezolinetant). Also being studied for endocrine-therapy-induced hot flashes in breast cancer survivors.

Mechanism

Dual neurokinin 1 + neurokinin 3 receptor antagonist; the NK1 component additionally improves sleep and mood vs fezolinetant's NK3-only mechanism; same hypothalamic KNDy-circuit normalization for VMS

Dose & route

120 mg PO once daily

Common questions

Does Elinzanetant (Lynkuet) work?
Read Off Label rates the evidence for Elinzanetant (Lynkuet) as Strong and the benefit magnitude as high, producing an overall grade of A- (7.6/10). Bayer; brand Lynkuet.
Is Elinzanetant (Lynkuet) safe?
Elinzanetant (Lynkuet) has a low-med risk profile in published human data. Legal status: Rx (approved EMA/several countries 2025; FDA filing in progress). This is not medical advice — see the disclaimer.
What is the typical dose for Elinzanetant (Lynkuet)?
120 mg PO once daily
How does Elinzanetant (Lynkuet) work?
Dual neurokinin 1 + neurokinin 3 receptor antagonist; the NK1 component additionally improves sleep and mood vs fezolinetant's NK3-only mechanism; same hypothalamic KNDy-circuit normalization for VMS

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.